Maen Saleh
Neurology · Garden City, MINPI 1457001653
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,313, more than ten times the $194 reported in 2022.
Across 113 payments — averaging $37.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$632
- Neurocrine Biosciences, Inc.$402
- Teva Pharmaceuticals USA, Inc.$355
- AbbVie$344
- AstraZeneca$333
- CSL Behring$270
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,254100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 17 | $632 |
| Neurocrine Biosciences, Inc. | 16 | $402 |
| Teva Pharmaceuticals USA, Inc. | 10 | $355 |
| AbbVie | 3 | $344 |
| AstraZeneca(2 entities) | 7 | $333 |
| CSL Behring | 8 | $270 |
| E.r. Squibb & Sons, L.L.C. | 3 | $265 |
| Biogen | 5 | $216 |
| Lundbeck LLC | 6 | $211 |
| Steris Corporation | 1 | $158 |
| Catalyst Pharmaceuticals, Inc. | 6 | $151 |
| Vanda Pharmaceuticals Inc. | 5 | $136 |
| Eisai Inc. | 2 | $125 |
| Pfizer | 1 | $100 |
| Livanova USA, Inc. | 2 | $95 |
| Lilly USA, LLC | 5 | $94 |
| Alnylam Pharmaceuticals Inc. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Tanabe Pharma America, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Argenx US, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,254 in reported general payments places this provider in the 65th percentile of 652 neurology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 12 | $521 |
Paid to pharmacies, not to this prescriber.
Other neurology in Garden City
- Andrew ZillgittGarden City$290K
- Aaron EllenbogenFarmington Hills$1.6M
- Matthew HoltzmanWayne$1.4M
- Richard TroschFarmington Hills$1.2M
- Wade CooperAnn Arbor$991K
- Bisena BulicaDetroit$900K
- Julie BurnhamMount Clemens$836K
- Amit MasihOkemos$785K
- Martin BelkinFarmington Hills$712K
- Robert PaceOwosso$693K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.